Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.

PHASE4TerminatedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 15, 2016

Study Completion Date

April 15, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

dimethyl fumarate

120 mg and 240 mg delayed release capsules

DEVICE

Medication Event Monitoring System (MEMS)

The MEMS automatically compiles drug dosing history data by electronically recording the date and time of each opening of the medication container

BEHAVIORAL

Adherence counseling

A telephone call to discuss adherence and individualized strategies based on data collected via smart device (i.e., LCD reader)

Trial Locations (29)

22601

Research Site, Winchester

29464

Research Site, Mt. Pleasant

32174

Research Site, Ormond Beach

32607

Research Site, Gainesville

32960

Research Site, Vero Beach

33612

Research Site, Tampa

35209

Research Site, Homewood

40513

Research Site, Lexington

43221

Research Site, Columbus

43623

Research Site, Toledo

44320

Research Site, Akron

44870

Research Site, Sandusky

46410

Research Site, Merrillville

63141

Research Site, St Louis

67214

Research Site, Wichita

78681

Research Site, Round Rock

80045

Research Site, Aurora

80907

Research Site, Colorado Springs

85018

Research Site, Pheonix

90095

Research Site, Los Angeles

91402

Research Site, Panorama City

92011

Research Site, Carlsbad

95816

Research Site, Sacramento

97225

Research Site, Portland

97701

Research Site, Bend

06824

Research Site, Fairfield

04210

Research Site, Auburn

02135

Research Site, Boston

29653-9181

Research Site, Hodges

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY